Columbia Banking System: Massive Share Repurchase And A 5% Yield

Novartis: Strong Drug Growth Faces A Tougher Test As Patent Losses And Pipeline Setbacks Mount

2026-10-25

Nokia: The Growth Of AI Networks Offers Strong Opportunities

2026-10-25

Sell Micron: Don't Wait For Memory Boom To End

2026-10-25

Enova: Growing 33% Without A Bank, Still Trades At 10x Earnings (Buy)

2026-10-25

Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity

2026-10-25